A STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF AN ANTI-IFN-GAMMA MAB IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) DEVELOPING MACROPHAGE ACTIVATION SYNDROME/ SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (MAS/SHLH):